Conference Coverage
News
First comorbidity guidelines drafted for psoriatic arthritis
Conference Coverage
Axial involvement found common in psoriatic arthritis mutilans
Key clinical point: In a review of a relatively large series of patients with PsA mutilans, radiographic evidence of axial disease was found in...
Conference Coverage
Patients become full partners in inflammatory arthritis and psoriasis research
Conference Coverage
Experts disagree on skin endpoint in psoriatic arthritis
Key clinical point: Experts in psoriatic arthritis agree that a treat-to-target approach should be applied to skin involvement but remain divided...
Conference Coverage
Treat to target shows durable improvements in psoriatic arthritis
Conference Coverage
Apremilast appears to have multiple, lasting benefits in psoriatic arthritis
Key clinical point: Apremilast maintained its efficacy and safety profile through 1 year of treatment.Major finding: At 52 weeks, 55%-63% of...
Conference Coverage
Apremilast’s positive study results made it the talk of ACR 2013
Major finding: After 16 weeks of treatment, the investigational drug apremilast achieved an ACR20 response of 29.2% at 20 mg twice daily as first-...
Conference Coverage
Treat-to-target approach for psoriatic arthritis found beneficial
Major finding: At 48 weeks, a higher proportion of psoriatic arthritis patients in the intensive management group achieved ACR70, compared with...
Conference Coverage
Apremilast effects sustained at 1 year in psoriatic arthritis
Major finding: ACR 20 response at 1 year was 57%-63% for patients given apremilast.Data source: PALACE 1, a 504-patient, phase III, multicenter,...